BTS
IMMU

BB&T Securities’s Immunomedics Inc IMMU Stock Holding History

BB&T Securities’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$661K Buy
49,750
+27,000
+119% +$397K 0.01% 979
2019
Q2 		$315K Buy
22,750
+10,000
+78% +$150K ﹤0.01% 1297
2019
Q1 		$244K Buy
+12,750
New +$206K ﹤0.01% 1401

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return

BB&T Securities's IMMU Position: Q3 2019 in Review

BB&T Securities increased its Immunomedics Inc (IMMU) stake by 119% in Q3 2019, buying an estimated $397K and bringing the position to 49,750 shares worth $661K. The position accounts for 0.01% of the portfolio, ranked #979.

BB&T Securities first reported a position in IMMU in Q1 2019 and has held it in 3 quarters since. 208 funds tracked by Wall St. Rank hold IMMU as of Q3 2019.

  • BB&T Securities held 49,750 shares of Immunomedics Inc worth $661K as of Q3 2019.
  • BB&T Securities bought 27,000 Immunomedics Inc shares in Q3 2019, an estimated $397K.
  • Immunomedics Inc made up 0.01% of BB&T Securities's portfolio in Q3 2019, its #979 holding.
  • BB&T Securities first reported a position in Immunomedics Inc in Q1 2019 and has held it in 3 quarters since.
  • 208 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.